# A Clinical Study in Healthy Male Volunteers to Compare the Bioequivalence of Fixed Dose Combination of Eperisone Hydrochloride 50mg Plus Diclofenac Sodium 50mg as Capsule With Eperisone Hydrochloride 50mg and Diclofenac Sodium 50mg Tablets Under Fasting Conditions (Study 013-10)

> **NCT01306318** · NA · COMPLETED · sponsor: **Eisai Co., Ltd.** · enrollment: 24 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** eperisone hydrochloride plus diclofenac sodium capsule
- **DRUG:** eperisone hydrochloride tablet and diclofenac sodium tablet

## Key facts

- **NCT ID:** NCT01306318
- **Lead sponsor:** Eisai Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2015-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01306318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01306318, "A Clinical Study in Healthy Male Volunteers to Compare the Bioequivalence of Fixed Dose Combination of Eperisone Hydrochloride 50mg Plus Diclofenac Sodium 50mg as Capsule With Eperisone Hydrochloride 50mg and Diclofenac Sodium 50mg Tablets Under Fasting Conditions (Study 013-10)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01306318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*